Literature DB >> 10772871

Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, canada).

S R Rivard1, C Mura, H Simard, R Simard, D Grimard, G Le Gac, O Raguenes, C Férec, M De Braekeleer.   

Abstract

We report the clinical, biochemical, and genetic characteristics of 13 hemochromatosis patients from Saguenay-Lac-Saint-Jean in whom the first symptoms appeared before age 30. Although the mean age at onset of the first symptoms was 21. 5 years, their mean age at diagnosis was 23.8 years; the diagnosis was particularly delayed among women. Seventy-seven percent of the patients had hypogonadotrophic hypogonadism and 69% heart failure and/or cardiac arrhythmias. Genetic analysis of the HFE gene revealed heterozygosity for the C282Y mutation in 2 patients and for the S65C mutation in 2 others and homozygosity for the H63D mutation in 1 patient. The remaining 8 patients had no identified mutation in the HFE gene, although sequencing of all seven codons and intron-exon junctions was performed (5 patients). All 13 patients fulfill the clinical criteria of juvenile hemochromatosis and represent the largest cluster thus far reported. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772871     DOI: 10.1006/bcmd.2000.0271

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  3 in total

Review 1.  Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature.

Authors:  Nicholas G Angelopoulos; Anastasia K Goula; George Papanikolaou; George Tolis
Journal:  Osteoporos Int       Date:  2005-07-05       Impact factor: 4.507

2.  Iron Overload (with Attention to Genetic Testing and Diagnosis/Management of HFE Wild Type Patients).

Authors:  Narendra Siddaiah; Kris V Kowdley
Journal:  Curr Treat Options Gastroenterol       Date:  2006

3.  Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population.

Authors:  James C Barton; Charles A Rivers; Sandrine Niyongere; Sean B Bohannon; Ronald T Acton
Journal:  BMC Med Genet       Date:  2004-12-20       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.